Article info
PDFBasic and translational research
Extended report
A novel disease-modifying osteoarthritis drug candidate targeting Runx1
- Correspondence to Dr Fumiko Yano, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; yanof-ora{at}h.u-tokyo.ac.jp
Citation
A novel disease-modifying osteoarthritis drug candidate targeting Runx1
Publication history
- Accepted September 11, 2012
- First published October 5, 2012.
Online issue publication
June 29, 2021
Article Versions
- Previous version (29 June 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
- Data supplement 2 - Online supplement
- Data supplement 3 - Online supplement
- Data supplement 4 - Online supplement
- Data supplement 5 - Online supplement
- Data supplement 6 - Online figures
- Data supplement 7 - Online legends
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions